{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:16:45Z","timestamp":1775225805941,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.mehy.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T20:49:46Z","timestamp":1528404586000},"page":"59-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combined targeted ion channel therapy: Can it be an alternative choice for esophageal cancer patients?"],"prefix":"10.1016","volume":"117","author":[{"given":"Guochao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.mehy.2018.06.010_b0015","first-page":"367","article-title":"Current treatment options for the management of esophageal cancer","volume":"4","author":"Mawhinney","year":"2012","journal-title":"Cancer Manage Res"},{"issue":"8","key":"10.1016\/j.mehy.2018.06.010_b0020","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1245\/s10434-013-2936-3","article-title":"Survival after recurrent esophageal carcinoma has not improved over the past 18 years","volume":"20","author":"Blom","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.mehy.2018.06.010_b0025","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. https:\/\/seer.cancer.gov\/csr\/1975_2014\/."},{"key":"10.1016\/j.mehy.2018.06.010_b0030","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbamem.2014.10.030","article-title":"Ion channels in the regulation of apoptosis","volume":"1848","author":"Kondratskyi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2018.06.010_b0035","doi-asserted-by":"crossref","first-page":"20130102","DOI":"10.1098\/rstb.2013.0102","article-title":"Ion channels and transporters in tumour cell migration and invasion","volume":"369","author":"Schwab","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.mehy.2018.06.010_b0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fncel.2015.00086","article-title":"Cancer as a channelopathy: ion channels and pumps in tumor development and progression","volume":"9","author":"Litan","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.mehy.2018.06.010_b0045","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/0008-5472.CAN-12-4188","article-title":"Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential","volume":"73","author":"Pedersen","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.010_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","article-title":"Targeting calcium signaling in cancer therapy","volume":"7","author":"Cui","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.mehy.2018.06.010_b0055","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/jnci\/djq217","article-title":"Essential role of TRPC6 channels in G2\/M phase transition and development of human glioma","volume":"102","author":"Ding","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.mehy.2018.06.010_b0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14728221003733602","article-title":"Targeting TRPC6 channels in oesophageal carcinoma growth","volume":"14","author":"Ding","year":"2010","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.010_b0065","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/gut.2009.181735","article-title":"Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer","volume":"58","author":"Shi","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.mehy.2018.06.010_b0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00281-015-0525-1","article-title":"Role of TRP ion channels in cancer and tumorigenesis","volume":"38","author":"Shapovalov","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.010_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13000-016-0457-7","article-title":"TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma","volume":"27","author":"Zhang","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.mehy.2018.06.010_b0080","article-title":"Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor","author":"Shiozaki","year":"2017","journal-title":"J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.010_b0085","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.18632\/oncotarget.1903","article-title":"Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma","volume":"5","author":"Zhu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2018.06.010_b0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1083\/jcb.201404136","article-title":"Targeting potassium channels in cancer","volume":"206","author":"Huang","year":"2014","journal-title":"J Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.mehy.2018.06.010_b0095","first-page":"48","article-title":"The biological significance of cell volume","volume":"16","author":"Lang","year":"1993","journal-title":"Ren Physiol Biochem"},{"key":"10.1016\/j.mehy.2018.06.010_b0100","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.18632\/oncotarget.3782","article-title":"Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.mehy.2018.06.010_b0105","doi-asserted-by":"crossref","first-page":"e0154471","DOI":"10.1371\/journal.pone.0154471","article-title":"Inhibition of SK4 potassium channels suppresses cell proliferation, migration and the epithelial-mesenchymal transition in triple-negative breast cancer cells","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2018.06.010_b0110","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.18632\/oncotarget.3517","article-title":"Silencing of voltage- gated potassium channel Kv9.3 inhibits proliferation in human colon and lung carcinoma cells","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcp.20748","article-title":"hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus","volume":"209","author":"Lastraioli","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.mehy.2018.06.010_b0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4161\/chan.21910","article-title":"Voltage-gated sodium channels and metastatic disease","volume":"6","author":"Brackenbury","year":"2012","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.mehy.2018.06.010_b0125","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1158\/0008-5472.CAN-10-1169","article-title":"Voltage - gated Na + channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion","volume":"70","author":"House","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2018.06.010_b0130","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1242\/jcs.130013","article-title":"Functional expression of the voltage- gated Na+- channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells","volume":"126","author":"Campbell","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.mehy.2018.06.010_b0135","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26210","article-title":"Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer","volume":"130","author":"Hernandez-Plata","year":"2012","journal-title":"Int J Cancer"},{"issue":"46","key":"10.1016\/j.mehy.2018.06.010_b0140","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.1523\/JNEUROSCI.3275-14.2014","article-title":"More than a pore: ion channel signaling complexes","volume":"34","author":"Lee","year":"2014","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2018.06.010_b0145","article-title":"A proteomics view on integrin-mediated adhesions","volume":"17","author":"Manninen","year":"2017","journal-title":"Proteomics"},{"issue":"5950","key":"10.1016\/j.mehy.2018.06.010_b0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/307465a0","article-title":"Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?","volume":"307","author":"DeCoursey","year":"1984","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.010_b0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00424-004-1258-5","article-title":"Roles of K+ channels in regulating tumour cell proliferation and apoptosis","volume":"448","author":"Wang","year":"2004","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.010_b0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-005-0776-1","article-title":"Role of voltage-gated potassium channels in cancer","volume":"205","author":"Pardo","year":"2005","journal-title":"J Membr Biol"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.010_b0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","article-title":"Ion channels and cancer","volume":"205","author":"Kunzelmann","year":"2005","journal-title":"J Membr Biol"},{"key":"10.1016\/j.mehy.2018.06.010_b0170","doi-asserted-by":"crossref","unstructured":"Arcangeli A. Expression and role of hERG channels in cancer cells. Novartis Found Symp. 2005; 266:225\u201332; discussion 232\u20134.","DOI":"10.1002\/047002142X.ch17"},{"issue":"1638","key":"10.1016\/j.mehy.2018.06.010_b0175","doi-asserted-by":"crossref","first-page":"20130105","DOI":"10.1098\/rstb.2013.0105","article-title":"Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation","volume":"369","author":"Fraser","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0180","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2102-9","article-title":"Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer","volume":"134","author":"Yang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.010_b0185","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-08-3303","article-title":"A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma","volume":"15","author":"Yip","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.mehy.2018.06.010_b0190","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-07-5710","article-title":"Eag1: an emerging oncological target","volume":"68","author":"Pardo","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00018-012-1039-9","article-title":"Na+, K+-ATPase as a docking station: protein-protein complexes of the Na+, K+ -ATPase","volume":"70","author":"Reinhard","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.mehy.2018.06.010_b0200","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.biocel.2005.04.002","article-title":"Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells","volume":"37","author":"O'Grady","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.mehy.2018.06.010_b0205","first-page":"285","article-title":"Voltage-gated potassium channels in cell proliferation","volume":"19","author":"Pardo","year":"2004","journal-title":"Physiology (Bethesda)"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.010_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002329900135","article-title":"Potassium channels, proliferation and G1 progression","volume":"154","author":"Wonderlin","year":"1996","journal-title":"J Membr Biol"},{"issue":"12","key":"10.1016\/j.mehy.2018.06.010_b0215","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"39","key":"10.1016\/j.mehy.2018.06.010_b0220","doi-asserted-by":"crossref","first-page":"32881","DOI":"10.1074\/jbc.M112.357889","article-title":"Nifetepimine, a dihydropyrimidone, ensures CD4+ T cell survival in a tumor microenvironment by maneuvering sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA)","volume":"287","author":"Ghosh","year":"2012","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.mehy.2018.06.010_b0225","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.2174\/1381612823666170530105837","article-title":"Ion channel and neurotransmitter modulators as electroceutical approaches to the control of cancer","volume":"23","author":"Tuszynski","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.010_b0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood.V49.3.345.345","article-title":"Electrolyte and acid-base disturbances in the management of leukemia","volume":"49","author":"O'Regan","year":"1977","journal-title":"Blood"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730912X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771730912X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T01:45:48Z","timestamp":1604367948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771730912X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":46,"alternative-id":["S030698771730912X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.06.010","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined targeted ion channel therapy: Can it be an alternative choice for esophageal cancer patients?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}